Trials / Not Yet Recruiting
Not Yet RecruitingNCT06070272
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
Investigating the Dynamics of Patient Engagement and Trends in Participation in Recurrent Prostate Cancer Clinical Trials
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Power Life Sciences Inc. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to endorse their broader utilization. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with recurrent prostate cancer.
Conditions
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-10-01
- Completion
- 2026-10-01
- First posted
- 2023-10-06
- Last updated
- 2023-10-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06070272. Inclusion in this directory is not an endorsement.